Taro Pharmaceutical
TARO
#5055
Rank
S$2.09 B
Marketcap
S$55.68
Share price
0.00%
Change (1 day)
4.74%
Change (1 year)

Revenue for Taro Pharmaceutical (TARO)

Revenue in 2023 (TTM): S$0.81 Billion

According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM ) is S$0.79 Billion. an increase over the revenue in the year 2022 that were of S$0.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taro Pharmaceutical from 1996 to 2023

Annual revenue

Year Revenue Change
2023 S$0.80 B5.64%
2022 S$0.76 B-0.28%
2021 S$0.76 B0.57%
2020 S$0.76 B-13.08%
2019 S$0.87 B-3.61%
2018 S$0.90 B-0.54%
2017 S$0.91 B-33.41%
2016 S$1.37 B4.32%
2015 S$1.31 B23.51%
2014 S$1.06 B14.01%
2013 S$0.93 B17.34%
2012 S$0.79 B21.56%
2011 S$0.65 B29.71%
2010 S$0.50 B0.55%
2009 S$0.50 B
2005 S$0.50 B8.51%
2004 S$0.46 B-13.51%
2003 S$0.53 B45.99%
2002 S$0.36 B32.09%
2001 S$0.27 B54.49%
2000 S$0.17 B28.95%
1999 S$0.13 B26.68%
1998 S$0.11 B6.9%
1997 S$0.10 B30.28%
1996 S$79.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
S$81.36 B 10,178.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$83.24 B 10,416.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.41 B 14,985.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.74 B 2,646.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$54.88 B 6,833.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$73.05 B 9,128.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland